
RadNet’s DeepHealth strikes $103m deal to acquire iCAD
RadNet company DeepHealth has signed a $103m deal to acquire iCAD, an AI-powered breast cancer screening company based in New Hampshire, US. The merger agreement’s terms equate to an all-stock buyout of iCAD at approximately $3.61 per share on a fully …